FEVER OF UNKNOWN ORIGIN: DIAGNOSTIC CHALLENGES FROM INFECTIOUS DISEASES PERSPECTIVE

Authors

  • Kostadin Poposki University Clinic for Infectious Diseases and Febrile Conditions, Faculty of Medicine, Ss. 2Cyril and Methodius University in Skopje, North Macedonia
  • Krsto Grozdanovski University Clinic for Infectious Diseases and Febrile Conditions, Faculty of Medicine, Ss. 2Cyril and Methodius University in Skopje, North Macedonia
  • Marija Dimzova University Clinic for Infectious Diseases and Febrile Conditions, Faculty of Medicine, Ss. 2Cyril and Methodius University in Skopje, North Macedonia
  • Dajana Georgievska University Clinic for Infectious Diseases and Febrile Conditions, Faculty of Medicine, Ss. 2Cyril and Methodius University in Skopje, North Macedonia
  • MIle Bosilkovski University Clinic for Infectious Diseases and Febrile Conditions, Faculty of Medicine, Ss. 2Cyril and Methodius University in Skopje, North Macedonia

Keywords:

Fever of unknown origin, potential diagnostic clues, infectious etiology

Abstract

Aim: To evaluate the diagnostic value of potentially diagnostic clues in distinguishing infectious from non-infectious causes of fever of unknown origin (FUO).

Material and methods: We conducted a retrospective–prospective, single-center study involving patients older than 14 years who met the criteria for classical FUO. Medical history, physical examination findings, and a standardized laboratory panel were collected for all participants. After the final diagnosis, patients were divided into infectious and non-infectious groups. Demographic characteristics, clinical features, and laboratory results were compared between groups.

Results: A total of 79 patients were included, with a mean age of 50.6±17.1 years (range 15–77). Males represented 61.1% of cases and were more common in the infectious FUO group (p=0.016), with this group showing higher febrile peak (p<0.001). Infectious diseases accounted for 51.9% of cases. In this group, notable clinical findings included fatigue (sensitivity 63.4%), fever (sensitivity 75.6%), heart murmur (positive likelihood ratio [+LR] 4.8), and splenomegaly (+LR 2.23). Key features of the non-infectious group were arthralgia (+LR 3.96), neck pain (+LR 3.49), joint swelling (+LR 6.44), and rash (+LR 3.49). Elevated procalcitonin (p=0.006), ALT (p=0.04), AST (p=0.02), and globulin levels (p=0.016) was noted in infectious FUO, while ferritin (p=0.047) and LDH (p=0.03) were higher in the non-infectious group.

Conclusions: The identified differences in diagnostic variables between infectious and noninfectious causes of classical FUO may assist initial etiologic differentiation and improve utilization of the diagnostic process.

References

Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine (Baltimore) 1961; 40: 1-30. doi: 10.1097/00005792-196102000-00001.

Durack DT, Street AC. Fever of unknown origin reexamined and redefined. Curr Clin Top Infect Dis. 1991; 11: 35-51. PMID: 1651090.

de Kleijn EM, Vandenbroucke JP, van der Meer JW. Fever of unknown origin (FUO). A prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine (Baltimore) 1997; 76(6): 392-400. doi: 10.1097/00005792-199711000-00002.

Bleeker-Rovers CP, Vos FJ, Mudde AH, Dofferhoff ASM, De Geus-Oei L-F, Rijnders AJ, et al. A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin. Eur J Nucl Med Mol Imaging 2007; 34(5): 694-703. doi: 10.1007/s00259-006-0295-z.

Cunha BA. Fever of unknown origin: focused diagnostic approach based on clinical clues from the history, physical examination, and laboratory tests. Infect Dis Clin North Am 2007; 21(4): 1137-1187. doi: 10.1016/j.idc.2007.09.004.

Larson EB, Featherstone HJ, Petersdorf RG. Fever of undetermined origin: diagnosis and follow-up of 105 cases, 1970–1980. Medicine (Baltimore) 1982; 61(5): 269-292. PMID: 6287162.

Gaeta GB, Fusco FM, Nardiello S. Fever of unknown origin: a systematic review of the literature for 1995–2004. Nucl Med Commun 2006; 27(3): 205-211. doi: 10.1097/00006231-200603000-00002.

Vanderschueren S, Knockaert D. Tackling fever and inflammation of unknown origin: the do’s and don’ts. Acta Clin Belg 2014; 69(6): 412-417. doi: 10.1179/2295333714Y.0000000070.

Takeda R, Mizooka M, Kobayashi T, Kishikawa N, Yokobayashi K, Kanno K, et al. Key diagnostic features of fever of unknown origin: medical history and physical findings. J Gen Fam Med 2017; 18(3): 131-134. doi: 10.1002/jgf2.35.

Campañá VR, Paneque REJ, Si̇lva HMR. Diagnostic utility of clinical and epidemiologic features in fever of unknown origin. Eur Res J 2019; 5(6): 928-938. https://doi.org/10.18621/eurj.441463.

Naito T, Torikai K, Mizooka M, Mitsumoto F, Kanazawa K, Ohno S, et al. Relationships between causes of fever of unknown origin and inflammatory markers: a multicenter collaborative retrospective study. Intern Med 2015; 54(16): 1989-1994. doi: 10.2169/internalmedicine.54.3313.

Erdem H, Baymakova M, Alkan S, Letaief A, Ben Yahia W, Dayyab F, et al. Classical fever of unknown origin in 21 countries with different economic development: an international ID-IRI study. Eur J Clin Microbiol Infect Dis 2023; 42(4): 1-12. https://doi.org/10.1007/s10096-023-04561-5.

Bosilkovski M, Dimzova M, Stevanovic M, Semenakova-Cvetkovska V, Vasileva-Duganovska M. Fever of unknown origin: diagnostic methods in a European developing country. Vojnosanit Pregl. 2016; 73(6): 553-558. doi: 10.2298/vsp140827050b.

Baymakova M, Plochev K, Dikov I, Popov G, Mihaylova R, Kovaleva V, et al. Fever of unknown origin in a Bulgarian hospital: evaluation of 54 cases for a four-year period. J Clin Anal Med 2016; 7(1): 70-75. doi: 10.4328/JCAM.3897.

Popovska-Jovicic B, Canovic P, Gajovic O, Rakovic I, Mijailovic Z. Fever of unknown origin: most frequent causes in adult patients. Vojnosanit Pregl 2016; 73(1): 21-25. doi: 10.2298/vsp140820128p.

Baicus C, Bolosiu HD, Tanasescu C, Baicus A. Fever of unknown origin: predictors of outcome. A prospective multicenter study on 164 patients. Eur J Intern Med 2003; 14(4): 249-254. doi: 10.1016/s0953-6205(03)00075-x.

Mete B, Vanli E, Yemisen M, Balkan II, Dagtekin H, Ozaras R, et al. The role of invasive and non-invasive procedures in diagnosing fever of unknown origin. Int J Med Sci 2012; 9(8): 682-689. doi: 10.7150/ijms.4591.

Berriatua E, Maia C, Conceição C, Özbel Y, Töz S, Baneth G, et al. Leishmaniases in the European Union and neighboring countries. Emerg Infect Dis 2021; 27(6):1723-1727. doi: 10.3201/eid2706.210239.

Cunha BA, Lortholary O, Cunha CB. Fever of unknown origin: a clinical approach. Am J Med 2015; 128(10): 1138.e1-1138.e15. doi: 10.1016/j.amjmed.2015.06.001.

Wright WF, Yenokyan G, Simner PJ, Carroll KC, Auwaerter PG. Geographic variation of infectious disease diagnoses among patients with fever of unknown origin: a systematic review and meta-analysis. Open Forum Infect Dis 2022; 9(5): ofac151. doi: 10.1093/ofid/ofac151.

Erdem H, Puca E, Ruch Y, Santos L, Ghanem-Zoubi N, Argemi X, et al. Portraying infective endocarditis: results of a multinational ID-IRI study. Eur J Clin Microbiol Infect Dis 2019; 38(9): 1753-1763. doi: 10.1007/s10096-019-03607-x.

Fusco FM, Pisapia R, Nardiello S, Cicala SD, Gaeta GB, Brancaccio G. Fever of unknown origin (FUO): which are the factors influencing the final diagnosis? A 2005–2015 systematic review. BMC Infect Dis 2019; 19(1): 653. doi: 10.1186/s12879-019-4285-8.

Vanderschueren S, Knockaert D, Adriaenssens T, Demey W, Durnez A, Blockmans D, et al. From prolonged febrile illness to fever of unknown origin: the challenge continues. Arch Intern Med 2003; 163(9): 1033-1041. doi: 10.1001/archinte.163.9.1033.

Robine A, Hot A, Maucort-Boulch D, Iwaz J, Broussolle C, Sève P. Fever of unknown origin in the 2000s: evaluation of 103 cases over eleven years. Presse Med. 2014; 43(9): e233-e240. doi: 10.1016/j.lpm.2014.02.026.

Torné Cachot J, Baucells Azcona JM, Blanch Falp J, Camell Ilari H. Classic fever of unknown origin: analysis of a cohort of 87 patients according to the definition with qualitative study criterion. Med Clin (Barc) 2021;156(5): 206-213. English, Spanish. doi: 10.1016/j.medcli.2020.03.014.

Wright WF, Yenokyan G, Auwaerter PG. Geographic influence upon noninfectious diseases accounting for fever of unknown origin: a systematic review and meta-analysis. Open Forum Infect Dis 2022; 9(8): ofac396. doi: 10.1093/ofid/ofac396.

van Griensven J, Diro E. Visceral leishmaniasis. Infect Dis Clin North Am 2012; 26(2): 309-322. doi: 10.1016/j.idc.2012.03.005.

Efstathiou SP, Pefanis AV, Tsiakou AG, Skeva II, Tsioulos DI, Achimastos AD, et al. Fever of unknown origin: discrimination between infectious and non-infectious causes. Eur J Intern Med 2010; 21(2): 137-143. doi: 10.1016/j.ejim.2009.11.006.

Vanderschueren S, Del Biondo E, Ruttens D, Van Boxelaer I, Wauters E, Knockaert DDC. Inflammation of unknown origin versus fever of unknown origin: two of a kind. Eur J Intern Med 2009; 20(4): 415-418. doi: 10.1016/j.ejim.2009.01.002.

Bosilkovski M, Baymakova M, Dimzova M. Fever of unknown origin (FUO): toward a uniform definition and classification system. J Clin Pract Res 2020; 42(2): 121-126. doi: 10.14744/etd.2020.56667.

Whicher J, Bienvenu J, Monneret G. Procalcitonin as an acute phase marker. Ann Clin Biochem 2001; 38(Pt 5): 483-493. doi: 10.1177/000456320103800505.

Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004; 39(2): 206-217. doi: 10.1086/421997.

Hu L, Shi Q, Shi M, Liu R, Wang C. Diagnostic value of PCT and CRP for detecting serious bacterial infections in patients with fever of unknown origin: a systematic review and meta-analysis. Appl Immunohistochem Mol Morphol 2017; 25(8): e61-e69. doi: 10.1097/PAI.0000000000000552.

Liu C-P, Liu Z-Y, Liu J-P, Kang Y, Mao C-S, Shang J. Diagnostic value of common inflammatory markers on fever of unknown origin. Jpn J Infect Dis 2016; 69(5): 378-383. doi: 10.7883/yoken.JJID.2015.470.

Kim SE, Kim UJ, Jang MO, Kang SJ, Jang HC, Jung SI, et al. Diagnostic use of serum ferritin levels to differentiate infectious and noninfectious diseases in patients with fever of unknown origin. Dis Markers 2013; 34: 211–218. https://doi.org/10.3233/DMA-130962.

Cunha BA. Fever of unknown origin (FUO): diagnostic importance of serum ferritin levels. Scand J Infect Dis 2007; 39(6-7): 651-652. doi: 10.1080/00365540601169729.

Jialal I, Sokoll LJ. Clinical utility of lactate dehydrogenase: a historical perspective. Am J Clin Pathol 2015; 143(2): 158-159. doi: 10.1309/AJCTP0FC8QFYDFA.

Huijgen HJ, Sanders GTB, Koster RW, Vreeken J, Bossuyt PMM. The clinical value of lactate dehydrogenase in serum: a quantitative review. Clin Chem Lab Med 1997; 35(8): 639-645. PMID: 9298346. https://doi.org/10.1515/cclm.1997.35.8.569.

Zhou Q, Xu X, Tan D, Xie Y, Long Y, Lu M. A clinical analysis of 293 FUO patients: a diagnostic model discriminating infectious from non-infectious diseases. Infect Int Electron Ed 2014; 3: 54–63. doi: 10.1515/ii-2017-0076.

Bilgin E, Hayran M, Erden A, Armağan B, Sarı A, Kılıç L, et al. Proposal for a simple algorithm to differentiate adult-onset Still’s disease with other fever of unknown origin causes: a longitudinal prospective study. Clin Rheumatol 2019; 38(6): 1699-1706. doi: 10.1007/s10067-019-04455-y.

Downloads

Published

2025-12-16

Issue

Section

Original Articles